Q1 2024 · 13F-HR
Artia Global Partners LPholdings as filed
Filed 2024-05-15 · accession 0001937964-24-000004
$497.5M
Reported value
49
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 532457958 | — | ELI LILLY & CO | $89.5M | 18.0% | 115,000 | PUT | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $88.8M | 17.9% | 691,743 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $72.0M | 14.5% | 92,593 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $50.0M | 10.1% | 379,200 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $35.6M | 7.15% | 433,580 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $16.5M | 3.32% | 90,821 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $14.5M | 2.92% | 210,096 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $13.5M | 2.71% | 34,238 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $12.9M | 2.60% | 190,752 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $12.1M | 2.43% | 28,900 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $7.0M | 1.41% | 87,848 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $6.6M | 1.33% | 724,685 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.3M | 1.26% | 89,525 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $6.2M | 1.25% | 45,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $5.4M | 1.09% | 87,040 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $5.2M | 1.05% | 76,255 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $4.1M | 0.82% | 61,590 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $4.0M | 0.81% | 85,765 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $3.6M | 0.72% | 124,440 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $3.4M | 0.68% | 119,488 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.2M | 0.64% | 118,236 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.7M | 0.53% | 53,930 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.4M | 0.48% | 15,894 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.3M | 0.46% | 52,492 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $2.3M | 0.45% | 50,171 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $2.1M | 0.42% | 130,790 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $2.0M | 0.41% | 51,714 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $1.9M | 0.38% | 6,905 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.8M | 0.36% | 47,949 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.8M | 0.35% | 40,924 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.7M | 0.35% | 40,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.7M | 0.33% | 40,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.5M | 0.30% | 100,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.4M | 0.28% | 421,359 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.3M | 0.26% | 54,285 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.2M | 0.25% | 137,308 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $1.1M | 0.23% | 52,476 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $1.1M | 0.21% | 51,500 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.1M | 0.21% | 147,485 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $1.0M | 0.21% | 24,298 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $942,183 | 0.19% | 64,007 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $842,066 | 0.17% | 39,478 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $691,337 | 0.14% | 21,397 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $530,007 | 0.11% | 35,452 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $441,662 | 0.09% | 58,190 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $415,781 | 0.08% | 1,557 | Common | SOLE |
| 28202V907 | — | EFFECTOR THERAPEUTICS INC | $359,750 | 0.07% | 25,000 | CALL | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $274,346 | 0.06% | 86,002 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $244,587 | 0.05% | 95,170 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.